PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.\', \'Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.\', \'Infectious Disease Unit, Massachusetts General Hospital, Boston, MA 02114, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: abalazs@mgh.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0092-8674(20)31685-810.1016/j.cell.2020.12.015
?:hasPublicationType
?:journal
  • Cell
is ?:pmid of
?:pmid
?:pmid
  • 33412089
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 25.137
?:rankingScore_hIndex
  • 682
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19-neutralizing antibodies predict disease severity and survival.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33412089>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33412089>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all